Last reviewed · How we verify
LEO 32731 gastro-resistant capsule — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
LEO 32731 gastro-resistant capsule (LEO 32731 gastro-resistant capsule) — LEO Pharma.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| LEO 32731 gastro-resistant capsule TARGET | LEO 32731 gastro-resistant capsule | LEO Pharma | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- LEO 32731 gastro-resistant capsule CI watch — RSS
- LEO 32731 gastro-resistant capsule CI watch — Atom
- LEO 32731 gastro-resistant capsule CI watch — JSON
- LEO 32731 gastro-resistant capsule alone — RSS
Cite this brief
Drug Landscape (2026). LEO 32731 gastro-resistant capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/leo-32731-gastro-resistant-capsule. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab